Minimizing Hypoglycemia in Diabetes

International Hypoglycaemia Study Group, and Campbell, Matthew (2015) Minimizing Hypoglycemia in Diabetes. Diabetes Care, 38 (8). pp. 1583-1591. ISSN 0149-5992

Full text not available from this repository.

Search Google Scholar

Abstract

Hypoglycemia caused by treatment with a sulfonylurea, a glinide, or insulin coupled with compromised defenses against the resulting falling plasma glucose concentrations is a problem for many people with diabetes. It is often recurrent, causes significant morbidity and occasional mortality, limits maintenance of euglycemia, and impairs physiological and behavioral defenses against subsequent hypoglycemia. Minimizing hypoglycemia includes acknowledging the problem; considering each risk factor; and applying the principles of intensive glycemic therapy, including drug selection and selective application of diabetes treatment technologies. For diabetes health-care providers treating most people with diabetes who are at risk for or are suffering from iatrogenic hypoglycemia, these principles include selecting appropriate individualized glycemic goals and providing structured patient education to reduce the incidence of hypoglycemia. This is typically combined with short-term scrupulous avoidance of hypoglycemia, which often will reverse impaired awareness of hypoglycemia. Clearly, the risk of hypoglycemia is modifiable.

Item Type: Article
Divisions: Faculty of Health Sciences and Wellbeing > School of Nursing and Health Sciences
Depositing User: Leah Maughan
Date Deposited: 14 Sep 2021 11:37
Last Modified: 14 Sep 2021 11:37
URI: http://sure.sunderland.ac.uk/id/eprint/13959
ORCID for Matthew Campbell: ORCID iD orcid.org/0000-0001-5883-5041

Actions (login required)

View Item View Item